Status:
COMPLETED
Testing Different Modes of Cognitive Behavior Therapy
Lead Sponsor:
Northwestern University
Conditions:
Depression
Literacy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test a novel behavioral treatment - Adapted Cognitive-Behavior Therapy (ACBT) - against standard Cognitive Behavior Therapy (CBT). The goal of the study is to determine...
Eligibility Criteria
Inclusion
- 18 years of age or older
- female
- diagnosis of major depressive disorder (MDD) according to DSM-5 (Diagnostic and Statistical Manual-5) (and no specifiers that pertain to exclusionary criteria (e.g. MDD with psychotic features)
- able and willing to give informed consent
- able to communicate in English
- willingness to be randomized to therapy
- willing to complete all study assessments
- at baseline, no plans to move from the Chicago area during the duration of the study
Exclusion
- history of bipolar disorder
- history of psychosis
- current substance use disorder of moderate or severe level of severity
- suicidal intentions or actions within the past three months
- known neurologic disease (e.g., multiple sclerosis, Parkinson's disease, cerebrovascular accident) and/or cognitive or neurologic impairment (e.g., Alzheimer's disease)
- current participation in other psychotherapy (not including psychiatric appointments pertaining to medication management)
- inadequate vision or hearing to interact with study materials
- being a prisoner, detainee, or being in police custody
- any current involvement in litigation
Key Trial Info
Start Date :
February 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04279028
Start Date
February 14 2020
End Date
November 15 2023
Last Update
February 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James W. Griffith
Chicago, Illinois, United States, 60611